Automated compound testing in zebrafish xenografts identifies combined MCL-1 and BCL-X <sub>L</sub> inhibition to be effective against Ewing sarcoma
Sarah Grissenberger(St Anna Children's Hospital), Martin Distel(St Anna Children's Hospital)
Cited by 0
Related Papers
Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts
|npj Precision Oncology|2023|44
A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in Vivo
|Cancers|2020|35